Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 2/20 | 0.34 |
| ▸ | RORC | P51449 | 1/20 | 0.31 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | CASP3 | P42574 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30709275 | 0.97 | KDM4E (0.32) | PTGER4KDM4EALDH1A1GLAGAA | |
| SCHEMBL30709291 | 0.94 | PTGER4 (0.36) | PTGER4 | |
| SCHEMBL30709476 | 0.87 | DUSP3 (0.32) | KDM4E | |
| SCHEMBL30709248 | 0.86 | NTRK1 (0.33) | KDM4E | |
| SCHEMBL30709418 | 0.86 | PTGER4 (0.37) | PTGER4RORCENPP3KDM4EALDH1A1 | |
| SCHEMBL30709277 | 0.84 | DNMT1 (0.31) | RORCALDH1A1CASP3 | |
| SCHEMBL31400229 | 0.83 | PTGER4 (0.36) | PTGER4RORCENPP3KDM4EALDH1A1 | |
| SCHEMBL30709496 | 0.82 | PTGER4 (0.33) | PTGER4KDM4EALDH1A1GLAGAA | |
| SCHEMBL22126464 | 0.82 | NTRK1 (0.30) | — | |
| SCHEMBL30709348 | 0.82 | NTRK1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11849634-B2 | Composition of matter for use in organic light- emitting diodes | KYULUX, INC. (JP) | 2023-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11849634-B2 | Composition of matter for use in organic light- emitting diodes | NDUFV3, NDUFV2, CRY2 | PTGER4 1328/4885RORC 863/4885ENPP3 2161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.